SME in quality system, compliance, audit, CMC, drug product, CMO oversight, packaging & labeling, risk management, gap assessment & remediation, and drug-device combination product.

Author CMC sections in IND/BLA/NDA and support PAI. Tech transfer and outsourced manufacturing in US, EU and Asia. Interim acting Head of Quality.

Experience at big pharma (Genentech Ph 2/3 IND) and start-ups (Intarcia Therapeutics, Lightsciences Oncology Ph 2/3 IND and NDA)

Audit (GMP, PAI, mock, DD), GMP compliance (21 CFR Part 211/820/4), quality systems, regulatory submission (IND, NDA/BLA), packaging (DS, DP, bottle, form/fill/seal), quality and supply agreement, batch record review & release, CAPA, deviation, change control, investigation, control strategy, risk management (HA, FMEAs), statistical analysis, complaint handling, biocompatibility, process validation (IQ/OQ/PQ), CMO oversight and management.